Skip to content
The Policy VaultThe Policy Vault

Xarelto (rivaroxaban tablets [generic for 2.5 mg tablet strength only] and oral suspension [generic])Cigna

Coronary Artery Disease

Initial criteria

  • Patient age ≥ 18 years
  • Patient is taking concomitant aspirin ≥ 75 mg daily
  • If rivaroxaban oral suspension (brand or generic product) is being requested, patient is unable to have Xarelto tablets appropriately administered

Approval duration

1 year